Advantages and Recent Developments of Autologous Cell Therapy for Parkinson’s Disease Patients

Parkinson’s Disease (PD) is a progressive degenerative disease characterized by tremor, bradykinesia, rigidity and postural instability. There are approximately 7–10 million PD patients worldwide. Currently, there are no biomarkers available or pharmaceuticals that can halt the dopaminergic neuron d...

Descripción completa

Detalles Bibliográficos
Autores principales: Osborn, Teresia M., Hallett, Penelope J., Schumacher, James M., Isacson, Ole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147334/
https://www.ncbi.nlm.nih.gov/pubmed/32317934
http://dx.doi.org/10.3389/fncel.2020.00058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147334/
https://www.ncbi.nlm.nih.gov/pubmed/32317934
http://dx.doi.org/10.3389/fncel.2020.00058

Ejemplares similares